✦ LIBER ✦

A dose-finding study of fondaparinux in patients with non–ST-segment elevation acute coronary syndromes: The Pentasaccharide in Unstable Angina (PENTUA) study

✍ Scribed by Maarten L. Simoons; Inge W.G. Bobbink; Jean Boland; Martin Gardien; Peter Klootwijk; Anthonie W.A. Lensing; Witold Ruzyllo; Victor A.W.M. Umans; Alec Vahanian; Frans Van De Werf; Uwe Zeymer

Book ID: 119264101
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 138 KB
Volume: 43
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2004.02.051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV47 COST-EFFECTIVENESS OF FONDAPARINUX

PCV47 COST-EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN IN PATIENTS WITH NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN BRAZIL

✍ C. Pepe; M. Machado; A. Olimpio; M. Canella; R. Ramos 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Comparative Pharmacodynamic Evaluation o

Comparative Pharmacodynamic Evaluation of Eptifibatide and Abciximab in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: The TAM2 Study

✍ Jorge F. Saucedo; Henry K. Lui; Luis Garza; G. Jose Guerra; Mary V. Jacoski; Lis 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 179 KB

Fondaparinux with UnfracTionated heparin

Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux

✍ Philippe Gabriel Steg; Shamir Mehta; Sanjit Jolly; Denis Xavier; Hans-Juergen Ru 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Obesity in patients with non-ST-segment

Obesity in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial

✍ Kenneth W. Mahaffey; Simon T. Tonev; Sarah A. Spinler; Glenn N. Levine; Richard 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Avoidance of routine revascularization i

Avoidance of routine revascularization in the management of patients with non-ST-segment elevation acute coronary syndromes

✍ William E Boden 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A cost-utility analysis of clopidogrel i

A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK

✍ J. Karnon; A. Bakhai; A. Brennan; A. Pandor; M. Flather; E. Warren; D. Gray; R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 185 KB